Information:
Fel:
Nyckelord
KLINICHESKOE ISSLEDOVANIE, IV FAZA ×
- Clinical Trial (114)
- Herpes Genitalis (39)
- HIV Infections (36)
- Hepatitis A Vaccines (36)
- Hematology (31)
- Thrombosis (30)
- Adverse event (18)
- Hematologic Tests (18)
- Laboratories (14)
- Eligibility Determination (13)
- Virology (12)
- Capsaicin (12)
- Demography (12)
- Concomitant Medication (8)
- Recurrence (6)
- Follow-Up Studies (6)
- Physical Examination (5)
- Vital Signs (5)
- Trial screening (5)
- Medical History Taking (5)
- Vaccines (4)
- Vaccination (3)
- Haemophilus influenzae type b (3)
- Meningococcal Vaccines (3)
- Neisseria meningitidis (3)
- Pharmacokinetics (2)
- Pregnancy Tests (2)
- Rheumatology (2)
- Drugs, Investigational (2)
- Urinalysis (2)
- Symptom Assessment (2)
- On-Study Form (2)
- Patient Reported Outcome (PRO) (2)
- End of Study (2)
- Herpes Simplex (2)
- Immunization, Secondary (2)
- Informed Consent (2)
- Patient Participation (2)
- Psychiatry (1)
- Psychology (1)
- Random Allocation (1)
- Restless Legs Syndrome (1)
- Asthma (1)
- Schizophrenia (1)
- Sleep Apnea Syndromes (1)
- Steroids (1)
- Surgical Procedures, Operative (1)
- Ultrasonography (1)
- Pulmonary Medicine (1)
- Diphtheria-Tetanus-Pertussis Vaccine (1)
- Comorbidity (1)
- Comment (1)
- Hepatitis B Vaccines (1)
- Clinical Trial, Phase III (1)
- Blood (1)
- Blood Coagulation (1)
- Blood Transfusion (1)
- Ventricular Dysfunction, Left (1)
- Chorionic Gonadotropin, beta Subunit, Human (1)
- Heart Valve Prosthesis Implantation (1)
- Osteoarthritis, Knee (1)
- Endpoint Determination (1)
- Consent Forms (1)
- Cardiology (1)
- Heart Failure, Systolic (1)
- Medication Adherence (1)
- Infectious Disease Medicine (1)
- Chemistry, Clinical (1)
- Informed Consent By Minors (1)
- Adrenergic beta-2 Receptor Agonists (1)
- Chondroitin Sulfates (1)
- Healthy Volunteers (1)
- PRO (1)
- Treatment Form (1)
- Patient information (1)
- Drug trial (1)
- Anticoagulation (1)
- Compliance (1)
- Depression (1)
- Endocrinology (1)
- Heart Failure (1)
- Hemorrhage (1)
- Hepatitis B (1)
- Hypothyroidism (1)
- Infection (1)
- Infusions, Intravenous (1)
- Meningitis, Meningococcal (1)
- Neurology (1)
- Antiviral Agents (1)
- Osteoarthritis (1)
- Pain (1)
- Aortic Valve Stenosis (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
132 Sökresultat.
Item-grupper: Study administration, HEMATOLOGY, CLINICAL CHEMISTRY
Item-grupper: Study administration, HEMATOLOGY, CLINICAL CHEMISTRY
Item-grupper: Inclusion Criteria, Exclusion Criteria
Item-grupper: Study administration, SERIOUS ADVERSE EVENTS, SERIOUS ADVERSE EVENTS, Seriousness, Demography Data, INSTRUCTIONS FOR COMPLETING SERIOUS ADVERSE EVENT FORMS, Possible Causes of SAE Other Than lnvestigational Products, RELEVANT Medical Conditions, Other RELEVANT Risk Factors, RELEVANT Concomitant Medications, Details of lnvestigational Products, Details of RELEVANT Assessments, Narrative Remarks
Item-grupper: Physical Examination, Vital Signs, ECG: 12 Lead ECG, Laboratory Tests: Hematology, Abnormal Lab tests: Hematology, Laboratory Tests: Biochemistry, Abnormal Lab tests: Biochemistry
Item-grupper: Pregnancy Test, Unscheduled Event
Item-grupper: Primary Diagnosis: Old diagnosis fields, Primary Diagnosis: New diagnosis fields, Physical Examination, Vital Signs, Height and Weight, ECG: 12 Lead ECG
Item-grupper: Inclusion Criteria, Exclusion Criteria
Item-grupper: Inclusion Criteria, Exclusion Criteria
Item-grupper: Inclusion Criteria, Exclusion Criteria
Item-grupper: Inclusion Criteria, Exclusion Criteria
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858 - 30-Day Followup (+/- 14 Days)
Item-grupper: Administrative Data, Followup visit, Vital Signs, Physical examination, Clinical Endpoints